3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Not yet recruiting
1
Sponsor Class
INDUSTRY
39
OTHER
13
NIH
6
OTHER_GOV
1
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Gastric Adenocarcinoma
1
Interventions
apatinib
2
Immunotherapy
2
Drug Therapy
2
spartalizumab
1
exemestane
1
darolutamide
1
dalpiciclib
1
citric acid, ispaghula husk, sodium bicarbonate drug combination
1
camrelizumab
1
Vi-siblin
1
Tamoxifen
1
Surgical Procedures, Operative
1
Stents
1
Standard of Care
1
Psyllium
1
Oxaliplatin
1
Mitomycin
1
Mammography
1
Magnetic Resonance Imaging
1
Low-Level Light Therapy
1
Lisaftoclax
1
Leucovorin
1
Laparotomy
1
Laparoscopy
1
Indocyanine Green
1
Gemcitabine
1
Fluorouracil
1
Everolimus
1
Endoscopy
1
Endoscopic Mucosal Resection
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER_GOV
×
130-nm albumin-bound paclitaxel
×
30 days
×
Clear all
NCT07610629
2026-05-28
RA-A-NP
Henan Cancer Hospital
Phase 2
Not yet recruiting
50 enrolled